[Retracted] Abnormal GRHL2 Methylation Confers Malignant Progression to Acute Leukemia

Figure 3

The methylation levels of GRHL2 gene promoter region in patients with acute leukemia and cell lines. (a) The methylation level of the GRHL2 promoter region in acute leukemia patients. (b) The methylation level of GRHL2 promoter region in acute leukemia cell lines. (c, d) The mRNA levels of the GRHL2 in acute leukemia cell lines after the use of the cell demethylation drug arsenic trioxide and 5-azacitidine. (e–h) The protein levels of GRHL2 in acute leukemia cell lines after the use of the cell demethylation drug arsenic trioxide and 5-azacitidine.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)